SORL1 mutation in a Greek family with Parkinson’s Disease and Dementia

Xiromerisiou G, Bourinaris T, Houlden H, Lewis PA, Senkevich K, Hammer M, Federoff M, Khan A, Spanaki C, Hadjigeorgiou GM, Bonstanjopoulou S, Fidani L, Ermolaev A, Gan-Or Z, Singleton AB, Vandrovcova J and Hardy J. SORL1 mutation in a Greek family with Parkinson’s Disease and Dementia. Annals of Clinical and Translational Neurology. 2021. PubMed

Clinical and genetic analysis of Costa Rican patients with Parkinson’s disease.

Torrealba-Acosta G*, Yu E* (equal contribution), Lobo-Prada T, Ruiz-Martínez J, Gorostidi-Pagola A, Gan-Or Z, Carazo-Céspedes K and Fornaguera-Trías J. Clinical and genetic analysis of Costa Rican patients with Parkinson’s disease. Frontiers in Neurology. 2021. PubMed, Preprint

Occurrence of amyotrophic lateral sclerosis in type 1 Gaucher disease. 

Oliveira LM, Rastin T, Nimmo GAM, Ross JP, Dion PA, Zhang M, Nevay DL, Arkadir D, Gotkine M, Barnett C, Shoesmith CL, Zimran A, Rogaeva EA, Zinman L, Rouleau GA, Gan-Or Z , Amato D and Kalia L. Occurrence of amyotrophic lateral sclerosis in type 1 Gaucher disease. Neurology Genetics. 2021. PubMed

Lack of Causal Relationship or Genetic Correlation between Restless Legs Syndrome and Parkinson’s Disease. 

Estiar MA, Senkevich K, Yu E, Varghaei P, Krohn L, Bandres-Ciga S, Noyce AJ, Rouleau GA and Gan-Or Z. Lack of Causal Relationship or Genetic Correlation between Restless Legs Syndrome and Parkinson’s Disease. Movement Disorders. 2021. PubMed, Preprint

Common and rare variants in HFE are not associated with Parkinson’s disease in Europeans.

Saini P, Bandres-Ciga S, Alcantud JL, Ruz C and Gan-Or Z. Common and rare variants in HFE are not associated with Parkinson’s disease in Europeans. Neurobiology of Aging. 2021. PubMed, Preprint

Analysis of PTRHD1 common and rare variants in European patients with Parkinson’s disease.

Sosero YL, Bandres-Ciga S, Gan-Or Z and Krohn L, on behalf of the International Parkinson’s Disease Genomics Consortium. Analysis of PTRHD1 common and rare variants in European patients with Parkinson’s disease. Neurobiology of Aging. 2021. PubMed, Preprint

Investigation of Autosomal Genetic Sex Differences in Parkinson’s disease.

Blauwendraat C, Iwaki H, Makarious MB, Bandres-Ciga S, Leonard H, Grenn FP, Lake J, Krohn L, Tan M, Kim JJ, Gibbs JR, Hernandez DG, Ruskey JA, Pihlstrøm L, Toft M, van Hilten JJ, Marinus J, Schulte C, Brockmann K, Sharma M, Siitonen A, Majamaa K, Eerola-Rautio J, Tienari PJ, Grosset D, Lesage S, Corvol JC, Brice A, Wood N, Hardy J, Gan-Or Z, Heutink P, Gasser T, Morris H, Noyce AJ, Nalls and Singleton AB. Investigation of Autosomal Genetic Sex Differences in Parkinson’s disease. Annals of Neurology. 2021. PubMed, Preprint

GCH1 mutations in hereditary spastic paraplegia.

Varghaei P, Yoon G, Estiar MA, Veyron S, Leveille E, Dupre N, Trempe JF, Rouleau GA and Gan-Or Z. GCH1 mutations in hereditary spastic paraplegia. Clinical Genetics. 2021. PubMed, Preprint

Type 2 diabetes as a determinant of Parkinson’s disease risk and progression.

(* equal contribution) Chohan H*, Senkevich K*, Patel RK, Bestwick JP, Jacobs BM, Bandres Ciga S, Gan-Or Z and Noyce AJ. Type 2 diabetes as a determinant of Parkinson’s disease risk and progression. Movement Disorders. 2021. PubMed, Preprint

No evidence for a causal relationship between cancers and Parkinson’s disease.

Senkevich K, Bandres-Ciga S, Yu E, Liyanage UE, the International Parkinson Disease Genomics Consortium (IPDGC), Noyce AJ and Gan-Or Z. No evidence for a causal relationship between cancers and Parkinson’s disease. Journal of Parkinson’s Disease. 2021. PubMed, Preprint